Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

被引：0
|
作者：
Yu, Irene
Cheung, Winson Y.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3576
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [1] Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer
    Yu, Irene S.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    Saif, M. W.
    Hashmi, Shahrukh
    Zelterman, Daniel
    Almhanna, Khaldoun
    Kim, Richard
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (02) : 139 - 145
  • [3] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    M. W. Saif
    Shahrukh Hashmi
    Daniel Zelterman
    Khaldoun Almhanna
    Richard Kim
    International Journal of Colorectal Disease, 2008, 23
  • [4] A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancer
    Peixoto, Renata D'Alpino
    Wan, Dante D.
    Schellenberg, Devin
    Lim, Howard J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 665 - 672
  • [5] COMPARISON OF CISPLATIN AND MITOMYCIN/5-FU AS RADIOSENSITIZERS IN THE TREATMENT OF VULVAR CANCER - RESULTS OF A SINGLE INSTITUTIONAL COHORT STUDY
    Linz, V.
    Schwanbeck, C.
    Anic, K.
    Jaekel, J.
    Schmidt, M. W.
    Krajnak, S.
    Schwab, R.
    Weikel, W.
    Seeger, A.
    Schmidt, M.
    Schmidberger, H.
    Hasenburg, A.
    Battista, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A350 - A350
  • [6] Comparison of the efficacy of bleb needling with 5-FU vs. Mitomycin
    Kranemann, C
    Ahmed, IK
    Crandall, AS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U373 - U373
  • [7] AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN
    Darba, J.
    Restovic, G.
    Ramirez de Arellano, A.
    VALUE IN HEALTH, 2008, 11 (06) : A466 - A466
  • [8] Concurrent radiochemotherapy with 5-FU/mitomycin remains standard treatment for anal carcinoma
    Nieder, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (06) : 512 - 513
  • [9] Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin vs 5-FU and cisplatin for anal canal carcinoma: Impact on disease-free, overall and colostomy-free survival
    Gunderson, L. L.
    Winter, K. A.
    Ajani, J. A.
    Pedersen, J. E.
    Benson, A. B.
    Thomas, C. R.
    Mayer, R. J.
    Haddock, M. G.
    Willett, C. G.
    Rich, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S24 - S24
  • [10] Postoperative adjuvant 5-FU/cisplatin and chemoradiation with capecitabine for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kown, H.
    Kim, M.
    Jung, G.
    Choi, H-J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
12345